MedDataX Logo

A Retrospective Cohort Study of HFRS

NCT ID: NCT06020326

Last Updated: 2023-08-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-05

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this retrospective cohort study is to learn about the clinial characteristics of HFRS patients, explore the risk factors of the occurrence and death of HFRS, and build a risk prediction model for HFRS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

HFRS remains an important public health issue in China, which not only poses a threat to people's physical health and safety, but also has a serious impact on social and economic development. At present, there is no unified standard for clinical prediction of the occurrence and death of HFRS. In order to better prevent and treat HFRS, this multicenter retrospective clinical study is designed to include HFRS inpatients, and collect their demographics, epidemiological history, hospitalization information, clinical manifestation, laboratory results, imaging results, treatment plan and outcome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HFRS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The patients must meet all of the following criteria:

* Inpatient with clinical diagnosis of Haemorrhagic Fever with Renal Syndrome

Exclusion Criteria

Exclude patients who meet any of the following criteria:

* Patients with previous chronic kidney disease
* Pregnant or perinatal patients
* Patients unsuitable for inclusion by investigators' evaluation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tongji Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qin Ning

Director, Department of Infection

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Qin Ning, Professor

Role: PRINCIPAL_INVESTIGATOR

Tongji Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

No.1 Peoples Hospital of Guangshui

Guangshui, Hubei, China

Site Status RECRUITING

Huanggang Central Hospital

Huanggang, Hubei, China

Site Status RECRUITING

People's Hospital of Luotian County

Huanggang, Hubei, China

Site Status RECRUITING

People's Hospital of Macheng City, Affiliated Hospital of Hubei University of Science and Technology

Macheng, Hubei, China

Site Status RECRUITING

Qianjiang Central Hospital

Qianjiang, Hubei, China

Site Status RECRUITING

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology

Wuhan, Hubei, China

Site Status RECRUITING

Xianning Central Hospital

Xianning, Hubei, China

Site Status RECRUITING

The Third Peoples Hospital of Yichang

Yichang, Hubei, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Qin Ning, Professor

Role: CONTACT

Phone: +8613971521450

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Qian Liu

Role: primary

Xiang Guo Zhu

Role: primary

Wei Wang

Role: primary

Yi Zhou

Role: primary

Jun Wang

Role: primary

Qin Ning

Role: primary

Jun Zhu

Role: primary

Quan Ming

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REHEAL

Identifier Type: -

Identifier Source: org_study_id